| INTRODUCTION
The use of continuous electroencephalographic (cEEG) monitoring for the diagnosis of nonclinical seizures/status epilepticus has grown tremendously in the past decade. 1 discharges (GPDs) or lateralized periodic discharges (LPDs), are the most common types of such patterns. They are noted in 12%-14% of all performed cEEGs. 2 Depending on various waveform characteristics, acute electrographic seizures are noted in 12%-58% of patients with PPs on cEEG. 2 Above findings along with a recently proposed cEEG-based risk scoring model for seizures during hospitalization 4 have vastly improved our understanding of acute impact of PPs. However, their impact on long-term, posthospitalization clinical outcomes is largely unknown. An immense number of electrographic data are generated by cEEG monitoring at the time of acute brain and systemic illness, which may potentially inform about the future risk of seizure recurrence and epilepsy. Based on this hypothesis, we previously investigated the incidence of clinical seizure recurrence after hospital discharge in a small cohort of patients with electrographic seizures and/or LPDs on cEEG. 5 As PPs are the most commonly noted as well as the most potentially epileptogenic findings acutely, the objective of our current study was to investigate the risk of development of epilepsy and factors associated with it among these patients and to compare this risk with a patient population without any epileptogenic findings on cEEG.
| MATERIALS AND METHODS
cEEG at our institute is a full 10-20 EEG recording system whereby patients typically undergo monitoring for at least 24 hours. It is performed most commonly in, but not restricted to, intensive care unit patients for indications that include suspected nonclinical seizures/status epilepticus as the cause of altered mental status and motor events concerning for epileptic seizures (eg, myoclonic jerks or transient unilateral posturing in comatose patients), or as part of therapeutic hypothermia protocol after, for example, cardiac arrest. cEEG is monitored at all times in our central monitoring unit by a rotating pool of certified EEG technicians who provide as needed/requested updates to treating teams throughout the day. All cEEGs are reviewed once in a 24-hour period by a staff physician, who generates the final daily report.
After institutional review board approval, we reviewed our prospectively maintained cEEG database from January 1, 2013 to June 30, 2013 followed by electronic medical record review to identify patients who fulfilled the inclusion and exclusion criteria detailed in Table 1 . The exclusion criteria prevented the inclusion of any patient who presented with a new onset epilepsy at the time of hospital admission (study population flowchart shown in Figure S1 ). The study population was divided into groups based on cEEG findings (primary predictor): LPDs and GPDs as defined per the 2012 American Clinical Neurophysiology Society criteria 6 and nonperiodic/nonepileptogenic (NP/ NE). Patients included in NP/NE group lacked LPDs or GPDs and further excluded patients with potentially epileptogenic findings (electrographic seizures, lateralized/regional rhythmic delta activity, 6 and isolated sharp waves/ spikes 7 ). The NP/NE patients were included to serve as a comparator group to the study population with PPs on cEEG. In a few cases with both LPDs and GPDs, patients were classified based on the first pattern to emerge. Underlying etiology associated with cEEG findings was classified as acute (within 7 days preceding cEEG monitoring initiation), remote, progressive (eg, tumors), anoxic brain insult, and toxic/metabolic/infectious encephalopathy (diagnosed when such reversible etiology led to improvement in altered mental status). Patients who had concomitant toxic/ metabolic/systemic infectious issues along with remote brain insult were categorized in the latter category, rather than as encephalopathy. The three cEEG groups were compared on demographics (age and gender), mental status at time of cEEG (awake/lethargy vs stupor/coma), motor events concerning for seizures prior to cEEG, electrographic seizure on cEEG (defined based on Salzburg criteria 8 and not differentiated into subclinical or nonconvulsive due to lack of precise clinical/video monitoring on cEEG at times), etiology, antiepileptic drug (AED) use at the time of discharge, and the clinical follow-up period. Primary outcome of the study was a spontaneous clinical seizure, after hospital discharge, outside of the acute symptomatic seizure period as previously defined. 9 • cEEG findings at the time of acute brain insult have the potential to serve as prognostic biomarkers for epilepsy development epilepsy. 10 Based on the findings from our previous study, 5 we did a separate analysis to investigate risk of epilepsy development in LPD patients with and without electrographic seizures in the current cohort of patient. The date of the first seizure after discharge was extracted from the electronic medical records, and the duration from the start of cEEG to the first seizure was used for the time-to-event analyses.
| Statistical methods
Categorical variables were described using frequencies and percentages, whereas continuous variables were described using medians and quartiles (first-third quartiles). The relationship between cEEG findings and categorical variables was described using Pearson chi-square tests, whereas the relationship between cEEG findings and continuous variables was described using Kruskal-Wallis tests. Ad hoc comparisons using a Bonferroni-corrected significance level of P ≤ .017 were used to evaluate pairwise differences between cEEG groups when overall differences existed. Kaplan-Meier estimates of epilepsy-free survival were created, and comparisons were made using Cox proportional hazard models for time-to-event analyses. Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated. Multivariate Cox proportional hazards models, adjusting for covariates one at a time, were fit. Analyses were performed using SAS software (version 9.4; SAS Institute, Cary, NC, USA).
| RESULTS
A total of 195 patients, including 111 (57%) women, with a median age of 67.8 (60.4-76.3) years constituted the study population. The median duration of cEEG monitoring was 2 (1-4) days. Indications for cEEG included suspected nonclinical seizures/status epilepticus as cause of altered mental status in 138 (70.8%) patients and motor events concerning for epileptic seizures in 50 (25.6%) patients, and as part of hypothermia protocol in the rest (details in Table S3 ). Based on cEEG findings, there were 53 (27% of the study population) patients in the LPD group, 73 (37%) patients in the GPD group, and 69 (35%) patients in the NP/NE group. As shown in Table 2 , there was no statistically significant difference between the three groups in terms of age, gender, mental status, motor events prior to cEEG, or etiology, except for progressive brain lesions, which were more likely to be present in the LPD group (P = .002). Based on the defining criteria, none of the patients in the NP/NE group had electrographic seizures, which were significantly higher in the LPD (24 patients; 45%) group compared to the GPD group (seven patients; 10%; P < .001). Patients with LPDs on cEEG were also more likely to be discharged on AEDs and had a shorter follow-up period compared to the other two groups (P < .001). The most commonly prescribed AED at the time of discharge was levetiracetam, with 42.1% of total study population, including 81.1% of patients in the LPD group (Table S4) . Also, 10.3% of total patients, including 32.1% of patients with LPDs, were discharged on multiple AEDs (Table S4) .
The primary outcome of spontaneous clinic seizure was noted in 29 (15%) patients during a median follow-up of 32.1 (13.2-42.8) months. Demographic, cEEG, and clinical details of these patients are available in Table 3 . In terms of various cEEG groups, the primary outcome was present in a significantly higher number of patients with LPDs (20 patients; 38%) compared to the GPD (four patients; 6%) or NP/NE (five patients; 7%) groups. The HR for development of epilepsy among LPD patients was 7.7 (95% CI = 2.9-20.7) times compared to the NP/NE group (Table S1 ). The HR for development of epilepsy was not significantly different between patients with GPDs and NP/NE findings on cEEG. The significantly higher likelihood of patients in the LPD group to develop epilepsy compared to the other two groups is shown in the Kaplan-Meier plot (Figure 1 ). The subanalysis of LPD patients with and without electrographic seizures showed both groups were at increased risk Table S2 ). This significance remained after adjusting for all other factors, except AEDs at discharge, which was highly associated with seizure, as all the patients with LPDs and seizures were discharged on AEDs (data not shown).
The median duration to epilepsy onset was shorter (median = 5.5 months), but statistically nonsignificant, in the LPDs group when compared to the other two groups (Table 2) . Time-to-event analysis showed that the risk of developing epilepsy during the follow-up period was statistically significant among patients with motor events prior to cEEG (HR = 2.36 [95% CI = 1. Table 4) . The model also showed a significant association of primary outcome with the presence of progressive brain insult, electrographic seizures on cEEG (P = .03), and discharge on AED (P = .04; Table 4 ).
| DISCUSSION
Our study shows that patients with LPDs on cEEG monitoring during critical illness are at a significantly elevated risk of developing epilepsy. This risk is more than seven times (HR = 7.7 [95% CI = 2.9-20.7]) greater than that of the patients who do not develop any periodic or epileptogenic patterns/discharges during acute illness. A close to 40% incidence of new onset epilepsy in patients with LPDs is a stark contrast to patients with GPDs (5.5%), who are at a similar risk of developing epilepsy as patients with NP/NE findings on cEEG (7.7%). Although not the primary aim of the study, our findings suggest that the presence of electrographic seizures may be an independent predictor of development of epilepsy. This is supported by a large increase in the risk for epilepsy development in LPD patients depending on the presence (HR = 11. This difference was lost for higher-frequency periodic discharges (PDs). 17 Small case series of patients with LPDs from the precEEG era 18 or non-cEEG emergent EEG recordings 19 have reported posthospitalization seizures in up to 48% of patients. Recently, we investigated patients with exclusively electrographic seizures and/or LPDs on cEEG and found that posthospitalization risk of epilepsy development ranged from 17% to 49%, depending on whether patients had only LPDs or both LPDs and electrographic seizures. 5 Lack of a comparative population prevented determination of increased risk of epilepsy in the abovementioned study. With more than one-third of patients with LPDs developing epilepsy in our current study, it may be reasonable to propose that LPDs at the time of acute brain insult may serve as a prognostic biomarker for chronic epilepsy | 1617 development. Evidence emerging from our prior study 5 was recently proposed to offer a patient population that was an "appropriate cohort for epilepsy-prevention trials." 20 This speaks to the promise of cEEG findings during acute illness to serve as a prognostic marker for epilepsy. We also found that the time to epilepsy development in these patients is relatively short (Table 2) . Therefore, an epilepsy prevention trial could possibly be successfully conducted within a reasonable follow-up period of a few years. A recent study of a fluid percussion injury model of traumatic brain injury in rats found that animals with repetitive highfrequency oscillations with spikes were at very high risk of developing late spontaneous focal seizures. 21 The repetitive nature of these spikes associated with high-frequency oscillations in this animal model of epileptogenesis, when extrapolated to humans, may be analogous to the LPDs noted among our study population.
A significant association was found between AED status at discharge and the development of epilepsy. This finding is likely an artifact due to 90% of LPD patients being discharged on AEDs in our study. This is likely a proxy for the elevated risk of acute seizures in patients with LPDs, which increases the likelihood of such patients being discharged on AEDs. This elevated risk may be extrapolated to epileptogenesis as well as among LPD patients, as a high number of these patients developed epilepsy despite being discharged on prophylactic AEDs. Conversely, whether the number of patients developing epilepsy in this group could have been even higher in the absence of such prophylactic AEDs can also be a reasonable point of debate. The most commonly used prophylactic AED in our cohort was levetiracetam. Interestingly, 30% of patients in the NP/NE group were discharged on AEDs as well. Previously, we found similar high rates of discharge on AEDs In etiology-adjusted analysis, acute brain insult was used as the reference group. "Other etiology" includes patients with anoxic, remote, and progressive brain insults. "Systemic encephalopathy" includes patients with toxic/metabolic/infectious encephalopathy. cEEG, continuous electroencephalogram; CI, confidence interval; GPD, generalized periodic discharge; HR, hazard ratio; LPD, lateralized periodic discharge.
T A B L E 4 Adjusted analyses for
predicting new onset epilepsy among patient with periodic patterns (LPDs or GPDs) on cEEG in a different study population where we tried to map the long-term, electrographic natural history of LPDs. 22 In that study as well, close to one-third (31%) of patients with LPDs developed epilepsy during a mean follow-up of 19.8 ± 9.9 months. 22 Several common traits for epileptogenesis across the etiological spectrum of symptomatic epilepsies are currently being recognized. 20 This is reflected in our study, as varied acute or progressive brain insults along with systemic encephalopathies led to common cEEG findings during acute illness and later epilepsy development. This also suggests that the presence of LPDs, independent of underlying etiology, is a risk factor for the development of epilepsy. We chose to use the new practical clinical definition of epilepsy 10 to define the primary study outcome because threefourths of our patient population had a structural brain lesion (Table 2 ) at the time of initial presentation. However, one-fourth of patients presented with toxic/metabolic/ infectious encephalopathy, which is considered not to leave any long-term structural changes in the brain. However, recent evidence from a large population-based cohort study has shown that survivors of sepsis, especially those with neurological dysfunction during hospitalization, are at significantly higher long-term risk of seizures compared to the general population and other hospitalized patients. 23 Patients with progressive brain insults like tumors in our cohort, not unsurprisingly, were at increased risk of developing epilepsy. There are several limitations to our study. Its retrospective nature and the determination of primary outcome through chart review leads to the introduction of selection and reporting bias. A small number of patients meeting the primary outcome during the follow-up period prevented us from simultaneously adjusting for all factors that may have differed between the cEEG groups. We used a 6-month study period from our institutional database, as we have a very high-volume cEEG program (as noted by 1069 adult cEEGs, Figure S1 ). However, there was a significant attrition due to high rate of mortality, study criteria-related exclusion, and lack of follow-up, likely due to many patients being referred to our institution for acute care and posthospitalization care performed locally. We used strict study population inclusion/exclusion criteria to help avoid the addition of patients with new onset epilepsy at the time of hospitalization. We did not evaluate individual PD modifiers, such as plus or sharply contoured morphological features, 6 or the duration of patterns and its relation to the development of epilepsy. Along with the presence of electrographic seizures, such PD-associated features may help explain the reason behind certain patients with LPDs being at increased risk to develop epilepsy in comparison with others. Our study was not designed to investigate the risk of epilepsy development in patients with sporadic epileptiform activity like sharp waves or spikes, 7 only electrographic seizures, or patients with patterns like lateralized/regional rhythmic delta activity. 6 In conclusion, our study shows certain cEEG findings at the time of critical illness have potential for prognosticating the risk of the development of symptomatic epilepsy. Among patients with PDs on cEEG during hospitalization, the presence of LPDs is associated with an almost eight times increased risk of developing epilepsy compared to patients with nonepileptogenic, nonperiodic findings, whereas patients with GPDs are at no greater risk. The presence of electrographic seizures seems to impart additional risk to the development of epilepsy later in life. Future prospective studies would be helpful in better defining the value of cEEG findings during acute settings as prognostic biomarkers for the development of symptomatic epilepsy.
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